AQC-Pattern Accordion-Collapse Accordion-Expand Agenda-Map CROs Consulting Download Email Fax Filter-Check Filter-Remove LinkedIn Map-Pin Member-Login Pharma-Biotech-Devices Phone Summit-Registration Survey-Research The-Avoca-Group-Consulting-And-Research-Services-Horizontal The-Avoca-Group-Diligent-Prequalification-Platform-Horizontal The-Avoca-Group-Quality-Consortium-Horizontal Training avoca-logo-coloravoca-logo-graycheckconsulting_logo2 diligent_logo2 dots dotted-01 dotted down-arrow GroupCreated with Sketch. minus plus quality_logo2 right-arrow twitter

Clinical Trial Optimization Podcast

Linda Sullivan, Senior Advisor, Metrics & Performance Management, WCG Avoca, discusses the major issues affecting you, from Quality-by-Design, to risk-based quality management and vendor oversight.

Subscribe today!

Apple Podcasts Spotify Stitcher Android

EPISODE 41

WCG Innovation Challenge Finalist Boston Children’s Hospital Discusses DEI Workforce Development Program with WCG Senior Advisor Linda Sullivan


EPISODE 40

WCG Innovation Challenge Winner Bayer Discusses Kits4Life Program with WCG Senior Advisor Linda Sullivan


EPISODE 39

How New Trial Designs & the Pandemic Have Altered Risk-Based Monitoring with Duncan Hall and WCG Senior Advisor Linda Sullivan


EPISODE 38

Deploying Advanced Analytics to Enhance QA, with Timothé Ménard and WCG Senior Advisor Linda Sullivan


EPISODE 37

The Evolving Role of the QA Professional with David Fryrear and WCG Senior Advisor Linda Sullivan


EPISODE 36

QTLs & Early Detection of Risk (Part III of the QTL Series) with Steve Young, Keith Dorricott, and WCG Senior Advisor Linda Sullivan


EPISODE 35

Defining QTLs & KRIs that Detect Risks in a Timely Manner (Part II) — The Process of Defining QTLs with Steve Young, Keith Dorricott, and WCG Senior Advisor Linda Sullivan


EPISODE 34

Defining QTLs and KRIs that Detect Risks in a Timely Manner – Part 1 Relationship of QTLs & KRIs with Steve Young, Keith Dorricott, and WCG Senior Advisor Linda Sullivan


EPISODE 33

Improving Enrollment of Underrepresented Racial and Ethnic Populations in Clinical Trials with WCG’s Lori Abrams and Senior Advisor Linda Sullivan


EPISODE 32

How the Pandemic Has Impacted Clinical Research Sites with WCG’s Sandy Smith and Senior Advisor Linda Sullivan


EPISODE 31

The MCC – Avoca Quality Consortium Integration — Latest Developments with WCG AQC VP Michelle Webb and Senior Advisor Linda Sullivan


EPISODE 30

Optimizing the Potential of Artificial Intelligence in Clinical Trials with Jonathan Rowe of ZS and MCC’s Linda Sullivan


EPISODE 29

What the New, Combined MCC/AQC Consortium Means for the Clinical Trials Industry with AQC’s Patty Leuchten and MCC’s Linda Sullivan


EPISODE 28

Highlights from 4th Annual WCG MCC Clinical Trial Risk and Performance Management Virtual Collaborative Summit with Keith Dorricott and Linda Sullivan


EPISODE 27

How Small Sponsors Can Best Access Clinical Trial Data with Lokavant’s Rohit Nambisan and Todd Johnson and Linda Sullivan


EPISODE 26

Outsourcing Oversight of RBQM in Clinical Trials with Liz Wool and Linda Sullivan


EPISODE 25

Grouping Investigative Sites into Risk Groups for “Fit for Purpose” Monitoring with Tammy Finnigan, Elizabeth Robertson, and Linda Sullivan


EPISODE 24

RBQM in Clinical Research with Cyntegrity’s Artem Andrianov and Johann Proeve and MCC’s Linda Sullivan


EPISODE 23

Optimizing Central Monitoring with Pfizer’s Crupa Kurien and Linda Sullivan


EPISODE 22

RBQM’s Maturity Model with Sam Sather of Clinical Pathways and Linda Sullivan


EPISODE 21

Optimizing Quality by Design with Keith Dorricott and Linda Sullivan


EPISODE 20

Optimizing Patient Diversity and Engagement with Lori Abrams and Linda Sullivan


EPISODE 19

Optimizing Clinical Trial Monitoring with Keith Dorricott and Linda Sullivan


EPISODE 18

How Organizations Can Take Advantage of Risk Assessment and Mitigation Management Tool To Optimize Clinical Trials with Keith Dorricott and Linda Sullivan


EPISODE 17

How Organizations Can Decide Which Metrics To Implement To Optimize Clinical Trials with Keith Dorricott and Linda Sullivan


EPISODE 16

How MCC Work Groups Develop Metric Toolkits with Keith Dorricott and Linda Sullivan


EPISODE 15

New Benchmarks on Protocol Design Practices and their Impact on Clinical Trial Performance and Efficiency with Ken Getz and Linda Sullivan


EPISODE 14

Twin Peaks — Measurements & Goals: Pros and Cons of Using High-Level Portfolio Milestone Timeliness Metrics with Linda Sullivan and Keith Dorricott


EPISODE 13

You’ve Detected a Risk … Now What?! The Challenges Organizations Face Accepting and Acting on Risks Identified by Centralized Monitoring with Linda Sullivan, Steve Young, and Keith Dorricott


EPISODE 12

Deploying Streamlined Surveys and Generating Metrics to Assess Vendor-Sponsor Relationships with Linda Sullivan and Keith Dorricott


EPISODE 11

TMF Accredited Training Program is Key To Building Your World-Class TMF with Linda Sullivan and Sholeh Ehdaivand


EPISODE 10

How the Right Metrics Enable You to Develop World-Class Sponsor-CRO Relationships with Linda Sullivan, Steve Crow, and Keith Dorricott


EPISODE 9

Implementing the Successful Total Cost of Quality Model in Clinical Trials: Yes, You Can — and Must — Eliminate Waste with Linda Sullivan and Keith Dorricott


EPISODE 8

Implementing Successful RBQM Programs Requires Three-Pronged Approach — It’s Not Just Software Implementation, with Linda Sullivan and Gary Tyson


EPISODE 7

Optimizing Human Performance in Clinical Trials by Applying Gilbert’s Behavioral Engineer Model with Linda Sullivan and SAM Sather


EPISODE 6

The Case for Centralized Monitoring: Optimizing Data Quality and Risk Management with Linda Sullivan and Steve Young


EPISODE 5

Striving for Reliability: Optimizing Patient-Reported Data through World-Class Design Management with Linda Sullivan, Nat Katz, and Art Morales


EPISODE 4

The Upside of Centralized Monitoring During a Pandemic: Linda Sullivan, Duncan Hall, and Rachel Oakley on Optimizing Clinical Trials through Innovative RBQM Technology


EPISODE 3

Get Rid of Those Silos: Linda Sullivan, Artem Andrianov, and Johann Proeve on How To Optimize Clinical Trials through RBQM


EPISODE 2

Turning Insights Into Action: Linda Sullivan and Ken Getz on How Metrics and Benchmarking Provide a Path To Optimizing Clinical Trials


EPISODE 1

A Discussion with Linda Sullivan and Laurie Halloran on Now Is the Time: Making Your Clinical Trial More Resilient